Published
Hear from Dr. Kim Branson, Senior Vice President of Global AI and ML at GSK on how massive datasets in drug discovery are pushing the boundaries of computing. Now is the time to bring together the best minds in medicine genetics and AI to build new AI algorithms and approaches across the drug discovery process.
Watch the full GTC 2020 keynote: https://nvda.ws/30Fa4Vl
#GTC20
Watch the full GTC 2020 keynote: https://nvda.ws/30Fa4Vl
#GTC20
Sign in or sign up to post comments.
Be the first to comment
Up Next
-
02:24
Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMo
-
01:14
NVIDIA and Schrödinger Partner to Accelerate Drug Discovery Worldwide
-
00:40
Drug Discovery Set for Deep Learning Transformation Powered by GPUs
-
01:22
Virtual Studio, XR, and AR with Brainstorm - NVIDIA M&E Partner Showcase
-
08:40
NVIDIA's GeForce Partner Program Is Bad News!
-
01:25
Speech Recognition with Speechmatics - NVIDIA M&E Partner Showcase
-
01:00
NVIDIA Volta Partner: Microway
-
01:03
NVIDIA Volta Partner: BOXX
-
12:00
NVIDIA GTC 2021 Keynote Part 5: DGX and the Language of Discovery
-
01:01
NVIDIA Tesla GPUs Supercharge Discovery at GTC 2018
-
02:33
Genentech and NVIDIA Revolutionize Drug Discovery with Generative AI in Lab in the Loop
-
03:12
NVIDIA at COMPUTEX 2024 Partner Highlights
-
00:57
NVIDIA Volta Partner: Advanced HPC
-
01:18
NVIDIA and RED Partner to Enable Real-Time 8K Video Editing
-
02:04
HERE, NVIDIA Partner on AI Technology for HD Mapping from Cloud to Car
-
01:06
NVIDIA Volta Partner: One Stop Systems
-
01:13
NVIDIA Volta Partner: Penguin Computing
-
36:02
NVIDIA Special Address at ISC22: Accelerating AI Innovation and Scientific Discovery
-
02:33
Partner With NVIDIA to Develop Customized AI Training Plans
-
00:52
Cloud Workflows for Media and Entertainment with AWS - NVIDIA M&E Partner Showcase
-
01:01
NVIDIA Volta Partner: Rave Computing
-
01:18
AI-Powered Super Slow-Motion with EVS - NVIDIA M&E Partner Showcase
Loading...